Associated Papers
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial.
Gómez Tejeda Zañudo J et al.
Nature Communications, 2024
38503755 (PubMed )
Supplement: 41467_2024_45835_MOESM7_ESM.xlsx › Mutation_calls_-_WES
Mutations in genes related to myocyte contraction and ventricular septum development in non-syndromic tetralogy of Fallot.
Harvey DC et al.
Frontiers in Cardiovascular Medicine, 2023
37840956 (PubMed )
Supplement: Table1.xlsx › Supp_Table_1
Systems Analysis Implicates WAVE2 Complex in the Pathogenesis of Developmental Left-Sided Obstructive Heart Defects.
Edwards JJ et al.
Jacc. Basic to Translational Science, 2020
32368696 (PubMed )
Supplement: mmc3.xlsx › Cases
Novel insights into the genetic landscape of congenital heart disease with systems genetics.
Gabriel GC et al.
Progress in Pediatric Cardiology, 2019
Cilia and Ciliopathies in Congenital Heart Disease.
Klena NT et al.
Cold Spring Harbor Perspectives in Biology, 2017
Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples.
Kosmicki JA et al.
Nature Genetics, 2017
28191890 (PubMed )
Supplement: NIHMS845776-supplement-5.xlsx › Congenital_Heart_Disease
High throughput in vivo functional validation of candidate congenital heart disease genes in Drosophila.
Zhu JY et al.
Elife, 2017
28084990 (PubMed )
Supplement: elife-22617-supp1.xlsx › Sheet1
De novo mutations in histone-modifying genes in congenital heart disease.
Zaidi S et al.
Nature, 2013
Select a paper to view details